Trademarkia Logo

Canada

C$
TPIREG
REGISTERED

on 18 Oct 2024

Last Applicant/ Owned by

Innomar Strategies Inc.

3470 Superior CourtOakville

ONTARIO

CA

L6L0C4

Serial Number

2153801 filed on 14th Dec 2021

Registration Number

TMA1263950 registered on 18th Oct 2024

Registration expiry Date

18th Oct 2034

Correspondent Address

MBM INTELLECTUAL PROPERTY AGENCY

275 SLATER STREET14TH FLOOROTTAWA

ONTARIO

CA

K1P5H9

TPIREG

Trademark usage description

regulatory submission management, namely, assisting others in preparing, reviewing and filing applications for new medical devices, medications, presc Read More

Classification Information


Class [035]
Regulatory submission management, namely, assisting others in preparing, reviewing and filing applications for new medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics with governmental regulatory bodies in Canada, the United States and around the world; regulatory submission management, namely, assisting others in preparing, reviewing and filing applications for New Drug Submissions (NDS, ANDS, SNDS), Product Monograph and Mock-up development as per Plain Language Labelling (PLL), Prescription to Non-Prescription Switch, Risk Management Plans (RMPs), Drug Submissions Relying on Third-Party Data (SRTD), Medical Device Establishment and License Applications (Class II, III, IV), Drug Identification Number (DIN) Submissions, Clinical Trial Applications (CTA) and Natural Health Product License Applications (PLAs) with governmental regulatory bodies in Canada; regulatory submission management, namely, assisting others in preparing, reviewing and filing applications for New Drug Applications (NDAs), Biologics License Applications (BLAs), Investigation New Drug Applications (INDs), Risk Evaluation and Mitigations (REMS), Drug Master Files (DMF) and Medical Device applications with governmental regulatory bodies in the United States; regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; business management consulting, strategic planning and business advisory services provided to medical, medical technology, pharmaceutical, biopharmaceutical, biotechnology and cosmetic companies, and government agencies, educational and research institutions in the fields of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, pharmaceutical, cosmetic and biotechnology companies to assist them with clinical research, clinical trials and applications for drug and product approval; business consulting services in the field of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; distribution and sale of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; commercialization of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; distribution of medical devices, medications, prescription and non prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; business consulting services, business strategy advisory services and marketing services relating to conducting of clinical trials; business consulting services, business strategy advisory services and marketing services relating to the commercialization of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; business consulting services, business strategy advisory services and marketing services relating to lead candidate drug optimization; business project management services in the fields of clinical and non-clinical programs, clinical and non-clinical drug development and research studies, clinical and non-clinical trials and proof of concept trials; recruiting patients and volunteers for clinical trials; design and development of market access strategies; market reports and studies; market analysis and research services; developing marketing strategies and marketing concepts for others; media relations services; investor relations services; management consulting services in the field of public affairs communications and government relations; strategic communication services in the fields of public relations, internal business relations, media relations, government relations, customer and client relations, stakeholder engagement, reputation management, and crisis management; policy and regulatory analysis services, namely, analysis of potential, proposed and existing policies, regulations and laws promulgated by federal, territorial, provincial and municipal Canadian departments, agencies, crown corporations, special operating agencies and organizations; provision of independent sales representatives in the fields of pharmaceuticals, biologics, drugs, medicines, medical devices, natural health products, cosmetics and non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; business marketing consulting services in the fields of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; business services provided to the health care industry, namely, consulting services, market intelligence, data collection for others in the field of market analysis and research, data submission management on behalf of medical, biopharmaceutical and biotechnology companies and patient management


Classification kind code

11

Class [042]
Research, development, design, testing and inspection of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; conducting early evaluations in the field of new medical devices, medications, prescription and non prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; providing information in the field of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; analysis of technical data and reporting, review and analysis of medical and clinical data for third parties and providing a report on the meaning of such data to third parties


Classification kind code

11

Class [045]
Regulatory compliance consulting services, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules pertaining to medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; regulatory compliance consulting in the fields of medical devices, medical technologies, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; tracking and monitoring regulatory compliance requirements for medical devices, medical technologies, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; regulatory compliance consulting, namely assisting clients with responses to regulatory authorities, advising on regulatory submission requirements, and consulting gap analyses and risk assessments in preparing regulatory submissions to governmental regulatory bodies in Canada, the United States and Europe; advisory services relating to regulatory compliance in the fields of medical devices, medical technologies, medications, prescription and non prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; advisory services related to regulatory compliance in the fields of drug advertising and promotion, regulatory and quality assurance for medical devices and medical diagnostic devices and registering and labelling medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; licensing of medical devices, medications, prescription and non-prescription pharmaceuticals and biologics, biopharmaceuticals, natural health products and cosmetics; drug market authorization services


Classification kind code

11

Mark Details


Serial Number

2153801

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 31st Jul 2024
Advertised
Submitted for opposition 26
on 4th Jul 2024
Approved
Submitted for opposition 27
on 4th Jul 2024
Approval Notice Sent
Submitted for opposition 22
on 5th Feb 2024
Search Recorded
Submitted for opposition 20
on 5th Feb 2024
Examiner's First Report
Submitted for opposition 67
on 30th Dec 2022
Agent Name Changed
Submitted for opposition 287
on 13th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 14th Dec 2021
Filed
Submitted for opposition 1
on 14th Dec 2021
Created
Submitted for opposition 31
on 14th Dec 2021
Formalized